This article provides a comprehensive comparison of Matrigel and laminin coatings for induced pluripotent stem cell (iPSC) culture, tailored for researchers and drug development professionals.
Sendai virus (SeV) vector technology has emerged as a leading method for generating induced pluripotent stem cells (iPSCs) without genomic integration, a critical safety consideration for clinical applications.
This article provides a comprehensive overview of the transformative role of induced pluripotent stem cell (iPSC)-derived motor neurons in modeling Amyotrophic Lateral Sclerosis (ALS).
Induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) have revolutionized cardiac arrhythmia research by providing a patient-specific platform for disease modeling, drug screening, and safety pharmacology.
This article provides a comprehensive and up-to-date analysis of the protocols for directly reprogramming somatic cells into induced pluripotent stem cells (iPSCs).
Feeder-free culture systems have revolutionized induced pluripotent stem cell (iPSC) research by providing defined, xeno-free conditions that enhance experimental reproducibility and clinical applicability.
This article provides a comprehensive overview of 3D cerebral organoids derived from human pluripotent stem cells (hPSCs), a revolutionary technology that recapitulates key aspects of human brain development.
This article explores the powerful synergy between CRISPR-Cas9 gene editing and induced pluripotent stem cell (iPSC) technology, a combination that is revolutionizing disease modeling and therapeutic development.
Kidney organoids derived from human induced pluripotent stem cells (iPSCs) have emerged as a transformative platform for modeling renal development and disease.
This article provides a comprehensive analysis of the process to differentiate human induced pluripotent stem cells (iPSCs) into functional, insulin-producing beta cells.